Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous versus intravenous diclofenac for pain control in ACL reconstruction
ACTRN12625000145404Phase 4Active, not recruiting
- Sponsor
- Simon Young (Waitemata DHB)
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of diclofenac in postoperative pain (2 arms), sponsored by Simon Young (Waitemata DHB). Primary endpoints: Pain score at rest and Pain score during mobilisation. Started Jun 2025; status: active, not recruiting.
02
Drugs
diclofenac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12625000145404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000145404.